Welcome to Grant for Multiple Sclerosis Innovation (GMSI)


The four award winners of the first GMSI were announced during the satellite symposium at the 29th congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Copenhagen, Denmark, on Saturday, October 5, 2013.

The five award winners of the second GMSI were announced during the satellite symposium at the Joint ACTRIMS-ECTRIMS Meeting held in Boston, USA on Friday, September 12, 2014.

The grant program is now in its third year. The window for submission to the GMSI 2015 award has now closed.

The website will be updated with the opening date of the 2016 grant following ECTRIMS 2015 congress.

The innovation grant will be awarded to support promising translational research projects by academic researchers to improve understanding of multiple sclerosis (MS) for the ultimate benefit of patients. Potential research topics that could be funded through the GMSI include MS pathogenesis, response to treatment and prediction of MS subtypes, identification of predictive or surrogate markers to allow better clinical decisions using currently available treatments as well as any potential new treatments, innovative patient support programs, mobile health devices, or patient-reported outcomes. To be eligible to apply, applicants must have preliminary data to support their proposal.